Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
YAYARWthis companyYarrow Bioscience Inc	$16.72	-0.94×	0.89×	43.53×	-0.03×	32.0%	96.0%	-5219.1%	-4646.1%	-95.4%	-107.1%	-133.5%	0×	0.9×	0×	12.53×	0.0%	3	18.08	2	C+
AIMAIM ImmunoTech Inc.	$0.16	-0.13×	-0.19×	20.78×	-0.45×	-2271.9%	-284.1%	-11961.4%	-15861.4%	142.7%	-313.6%	-619.7%	-0.5×	-0.31×	-12.96×	0.53×	0.0%	3	-51.36	2	C
ENSCEnsysce Biosciences, Inc.	$0.36	-0.23×	0.73×	0×	0.16×	-85.7%	0.0%	0.0%	0.0%	-316.6%	-320.9%	-337.1%	0.1×	0.39×	-545.69×	1.59×	0.0%	3	-82.13	2	C+
KALAKALA BIO, Inc.	$0.17	-0.17×	0.65×	0×	0.13×	24209.1%	0.0%	0.0%	0.0%	-385.6%	-559.8%	-706.1%	0×	0.32×	-11.95×	3.81×	0.0%	3	-92.87	2	B-
KTTAPasithea Therapeutics Corp.	$0.57	-0.44×	0.16×	0×	2.28×	2031.8%	0.0%	0.0%	0.0%	-37.0%	-37.7%	-167.7%	0×	2.73×	0×	11.35×	0.0%	2	1.38	2	B-
MTNBMatinas BioPharma Holdings, Inc.	$1.18	-0.29×	0.66×	0×	-0.06×	415.1%	0.0%	0.0%	0.0%	-214.2%	-108.1%	-218.6%	0.28×	0.27×	0×	2.79×	0.0%	1	-94.31	3	B-
Peer median	—	-0.23×	0.65×	0×	0.13×	415.1%	0.0%	0.0%	0.0%	-214.2%	-313.6%	-337.1%	0×	0.32×	-11.95×	2.79×	0.0%	3	-82.13	2	—